Aura Biosciences, Inc. (AURA) stock
Close on Nov 13, 2026Market cap $737.34MP/E –Yield –
Earnings
Aura Biosciences's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Aura Biosciences's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 29, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 9, 2026before the open | – | – | -$0.29 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 11, 2026before the open | – | – | – | Release |
| Q1 FY2026ended Mar 31, 2026 | May 11, 2026after the close | – | – | -$0.50 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 30, 2026before the open | – | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 13, 2025before the open | – | – | -$0.40 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 13, 2025before the open | – | – | -$0.47 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 15, 2025before the open | – | – | -$0.55 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 24, 2025after the close | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 12, 2024after the close | – | – | -$0.42 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 8, 2024before the open | – | – | -$0.41 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 9, 2024before the open | – | – | -$0.40 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 27, 2024before the open | – | – | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 9, 2023after the close | – | – | -$0.48 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 9, 2023before the open | – | – | -$0.48 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 11, 2023after the close | – | – | -$0.46 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 15, 2023after the close | – | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 10, 2022before the open | – | – | -$0.54 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 11, 2022after the close | – | – | -$0.46 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 12, 2022after the close | – | – | -$0.44 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 23, 2022after the close | – | – | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 24, 2021after the close | – | – | -$28.33 | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
No open guidance: every period Aura Biosciences guided for has been reported
Guidance history
Every forecast Aura Biosciences put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 11, 2026 | restructuring charges | Q3 FY2026 | $2.90M – $3.20M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Aura Biosciences filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Aura Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Business HighlightsResults
- Results
- Results
- Results
- Results
- Results
- News
- Results
See a number that looks wrong?